Bortrac – Bortizumab Injection
Description
BORTIZUMAB (BORTRAC) INJECTION – TREATMENT FOR MULTIPLE MYELOMA
Both mantle-cell lymphoma and multiple myeloma are treated with Bortracinjection. By halting or reducing the growth of cancer cells, it demonstrates its effectiveness.
A trained medical expert administers Bortrac Injection through injection. Your doctor will determine the appropriate dosage and frequency of administration for you. This is based on the condition you are being treated for and is subject to change.
Fedelty Health Care is a Bortizumab wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
USES OF BORTIZUMAB (BORTRAC) INJECTION
- Multiple myeloma
- Mantle-cell lymphoma
WORKS OF BORTIZUMAB (BORTRAC) INJECTION
An anti-cancer drug is called Bortrac Injection. It functions by preventing or delaying cellular protein deterioration. The result is an increase in the number of proteins, which causes the cancer cells to die.
WORKS OF BORTIZUMAB (BORTRAC) INJECTION
An anti-cancer drug is called Bortrac Injection. It functions by preventing or delaying cellular protein deterioration. The result is an increase in the number of proteins, which causes the cancer cells to die.
Â
SIDE EFFECTS OF BORTIZUMAB (BORTRAC) INJECTION
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hands)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
WARNING & PRECAUTIONS
- Driving
The negative effects of Bortrac injection may impair your ability to operate a motor vehicle.
Bortrac Injection may make you feel sleepy, woozy, dizzy, or have blurry vision, which could impair your ability to drive.
- Pregnancy
Bortrac Injection should not be used during pregnancy because there is clear evidence that it poses harm to the unborn child. However, if the advantages outweigh the possible risks, a doctor might very rarely recommend it in specific life-threatening circumstances. Please speak with your physician.
Fedelty Health Care is a  Bortizumab third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.
